Viewing Study NCT00267969


Ignite Creation Date: 2025-12-24 @ 10:49 PM
Ignite Modification Date: 2025-12-25 @ 8:18 PM
Study NCT ID: NCT00267969
Status: COMPLETED
Last Update Posted: 2013-06-17
First Post: 2005-12-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
Sponsor: Centocor Research & Development, Inc.
Organization: